FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs)
FDA today issued a public health advisory outlining new safety information, including revised product labeling about erythropoiesis-stimulating agents (ESAs), widely-used drugs for the treatment of anemia.